Table 4. Time to the initiation of treatment and stage distribution of colorectal cancer

Author	Publication year	Time to treatment start, days		P-value	Stage (%)			P-value
		Pre-COVID-19	COVID-19		Comparison	Pre-COVID-19	COVID-19
Cano-Valderrama O [34]	2023	4.8	6.4	<0.001	Stage I/II/III/IV	36.7/24.3/22.5/16.6	23.6/22.7/30.0/23.6	0.019
Pirozzi BM [33]	2023	14	15	NS	Stage I/II/III/IV	15/31.6/38.1/15.6	18/36.1/34.6/3.6	NS
Miyo M [25]	2022				Stage I/≥II	26.9/73.1	24.2/75.8	0.0011
Freund MR [26]	2022	8.7	11.1	0.0068	Metastasis	3	9	0.05
Rottoli M [27]	2022	-	-		Multiple liver metastasis	72.1	82.2	0.09
Chen MZ [28]	2022	54.9	54.3	NS	-	-	-
Tarta C [29]	2022	-	-		Stage IV	12	12 (2020) 20 (2021)
Meijer J [20]	2022	-	-		Stage I/II/III/IV	29.8/26.6/22.2/19	20/25.5/26.8/26.2-	<0.01
Ghosh S [30]	2022	-	-		Stage I/II/III/IV	32.3/28.4/28.9/6	22.2/33.3/31.9/8.3	NS
Tang G [31]	2022	6.46	5.18	0.0016		-	-
Kudou M [44]	2022	-	-		T4b	4.4	16.4	0.01
Uyan M [35]	2022	-	-		Stage I/II/III/IV	16/52/23/9	10/23/44/23	0.005
Kiss BI [36]	2022	-	-		T4b	12.4	18.9	0.026
Choi JY [13]	2021	-	-		Stage 0/I/II/III	3.1/25.1/34.2/37.7	4.3/26.7/31.2/37.8	NS
Kuryba A [40]	2021	-	-		Stage IV	37.8	24.9
Radulovic RS [45]	2021	-	-		T4b Stage IIA	3.3 27.6	20.2 12.2	<0.01 0.033

NS, non-specific.